Novo Nordisk | NVO - Los Gastos Financieros De La Deuda

Precio De Mercado
39.35
Cambio Diario
1.38 3.63%
Mensual
2.08%
Anual
-38.96%
Q2 Expectativa
35.64




Los Gastos Financieros De La Deuda Cambio Fecha
ANI Pharmaceuticals USD 4.41M 316K 2025-12
Aurora Cannabis CAD 2.11M 116K 2025-12
Bausch Health Companies USD 412M 53M 2025-09
Bristol-Myers Squibb USD 432M 48M 2025-12
Canopy Growth CAD 7.34M 1.46M 2025-12
Corcept Therapeutics USD 823.61M 21.88M 2025-09
Drreddys Laboratories INR 944M 127M 2025-12
Eli Lilly USD 114.7M 134.3M 2025-09
GlaxoSmithKline GBP 188M 21M 2025-12
Merck USD 412M 85M 2025-12
Nektar Therapeutics USD 9.77M 3.75M 2025-12
Novartis USD 304M 23M 2025-12
Novo Nordisk DKK 1.53B 3.43B 2025-09
Pacira USD 3.89M 387K 2025-12
Perrigo USD 10.08B 10.04B 2025-09
Phibro Animal Health USD 11.91M 191K 2025-12
Prestige Brands USD 10.67M 636K 2025-12
Sanofi EUR -25M 252M 2025-12
Supernus Pharmaceuticals USD 910K 278K 2023-06
Zoetis USD 57M 1000K 2025-12